相关实验视频

Updated: Jul 9, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

[CAR-T细胞治疗转移性割抵抗性前列腺癌的当前趋势]

Sayuri Takahashi¹

¹Dept. of Urology, The Institute of Medical Science, The University of Tokyo.

Gan to kagaku ryoho. Cancer & chemotherapy

|November 30, 2023

概括

针对前列腺特异性膜抗原 (PSMA) 的化学抗原受体T ((CAR-T) 细胞疗法对转移性割抵抗性前列腺癌 (mCRPC) 显示出希望. 国际试验表明潜在的安全性和有效性,为这种致命疾病提供了新的希望.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

前列腺癌,特别是转移性抵抗割的前列腺癌 (mCRPC),存在重大治疗挑战.
目前的疗法,如化疗和雄激素受体抑制剂在mCRPC中有效性有限.
CAR-T细胞疗法在血液性恶性瘤中取得了成功,但在固体瘤中面临障碍.

研究的目的:

审查构建针对mCRPC的CAR-T细胞的策略.
总结一下最近在mCRPC中针对抗PSMA CAR-T疗法的国际临床试验结果.
评估这种新型免疫疗法方法的安全性和有效性.

主要方法:

关于mCRPC的CAR-T细胞治疗的科学文献和临床试验数据的审查.
专注于旨在准前列腺特异性膜抗原 (PSMA) 的CAR-T细胞.
对正在进行的国际临床试验报告结果的分析.

主要成果:

开发针对PSMA的CAR-T细胞作为mCRPC的战略.
一些国际临床试验正在评估抗PSMACAR-T细胞.
初步结果表明,对mCRPC患者的安全性和疗效有希望.

结论:

抗PSMA CAR-T细胞疗法代表了治疗mCRPC的有希望的新策略.
目前正在进行的临床试验对于进一步验证其治疗潜力至关重要.
这种免疫治疗方法可能为晚期前列腺癌患者提供更好的结果.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.